...
机译:儿科甲状腺病变中致癌基因改变的分子检测
Division of Oncology The Children's Hospital of Philadelphia Philadelphia Pennsylvania.;
Asuragen Inc. Austin Texas.;
Division of Anatomic Pathology Department of Pathology;
Department of Pathology and Laboratory Medicine Hospital of the University of Pennsylvania;
Department of Biostatistics and Epidemiology University of Pennsylvania Philadelphia;
Department of Biostatistics and Epidemiology University of Pennsylvania Philadelphia;
Asuragen Inc. Austin Texas.;
Division of Pediatric Otolaryngology Department of Pediatric Surgery University of Pennsylvania;
Division of General Surgery Department of Pediatric Surgery University of Pennsylvania;
Department of Pathology and Laboratory Medicine Hospital of the University of Pennsylvania;
Division of Endocrinology and Diabetes Department of Pediatrics The Children's Hospital of;
pediatric thyroid cancer; oncogene testing;
机译:儿科甲状腺病变中致癌基因改变的分子检测
机译:甲状腺病变中致癌基因突变的分子检测:413例后勤标本中的病例对照验证研究
机译:通过联合检测miRNA基因表达和体细胞基因改变对甲状腺病变进行分子分类
机译:老化甲状腺功能测试的改变
机译:小儿胶质瘤发生中的新型致癌驱动因子。
机译:小儿甲状腺病变致癌基因改变的分子检测
机译:甲状腺良恶性病变中FHIT和p53基因的分子遗传学改变
机译:卵巢浆液性癌前体病变分子改变的阐明。